# Safety of Voriconazole in a Patient with CYP2C9*2/CYP2C9*2 Genotype

## Metadata
**Authors:** Marcus JP Geist, Gerlinde Egerer, Jürgen Burhenne, Gerd Mikus
**Journal:** Antimicrobial Agents and Chemotherapy
**Date:** 2006 Sep
**DOI:** [10.1128/AAC.00551-06](https://doi.org/10.1128/AAC.00551-06)
**PMID:** 16940139
**PMCID:** PMC1563530
**URL:** https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1563530/
**PDF:** [https://pmc.ncbi.nlm.nih.gov/articles/PMC1563530/pdf/0551-06.pdf](https://pmc.ncbi.nlm.nih.gov/articles/PMC1563530/pdf/0551-06.pdf)

## Acknowledgments

We are grateful to Johanna Weiss for the genotype analysis and for the excellent technical assistance of Jutta Kocher and Andrea Deschlmayr during analytical procedures.

The Department of Internal Medicine VI, Clinical Pharmacology and Pharmacoepidemiology, has received a grant from Pfizer, New York, to establish and make available an HPLC method for the determination of voriconazole in plasma which is validated according to Food and Drug Administration standards.

None of the authors has financial or personal relationships that could potentially be perceived as influencing the research described herein.

## References

1. Burian, M., S. Grosch, I. Tegeder, and G. Geisslinger. 2002. Validation of a new fluorogenic real-time PCR assay for detection of CYP2C9 allelic variants and CYP2C9 allelic distribution in a German population. Br. J. Clin. Pharmacol. 54:518-521.  [DOI](https://doi.org/10.1046/j.1365-2125.2002.01693.x) | [PMC free article](/articles/PMC1874480/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/12445031/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Br.%20J.%20Clin.%20Pharmacol.&volume=54&publication_year=2002&pages=518&pmid=12445031&doi=10.1046/j.1365-2125.2002.01693.x&)

2. Hyland, R., B. C. Jones, and D. A. Smith. 2003. Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole. Drug Metab. Dispos. 31:540-547.  [DOI](https://doi.org/10.1124/dmd.31.5.540) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/12695341/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Drug%20Metab.%20Dispos.&volume=31&publication_year=2003&pages=540&pmid=12695341&doi=10.1124/dmd.31.5.540&)

3. Lee, C. R., J. A. Goldstein, and J. A. Pieper. 2002. Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data. Pharmacogenetics 12:251-263.  [DOI](https://doi.org/10.1097/00008571-200204000-00010) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/11927841/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Pharmacogenetics&volume=12&publication_year=2002&pages=251&pmid=11927841&doi=10.1097/00008571-200204000-00010&)

4. Mikus, G., V. Schöwel, M. Drzewinska, J. Rengelshausen, R. Ding, K. D. Riedel, J. Burhenne, J. Weiss, T. Thomsen, and W. E. Haefeli. Potent CYP2C19 genotype related interaction between voriconazole and the CYP3A4 inhibitor ritonavir. Clin. Pharmacol. Ther., in press.  [DOI](https://doi.org/10.1016/j.clpt.2006.04.004) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/16890574/)

5. Pennick, G. J., M. Clark, D. A. Sutton, and M. G. Rinaldi. 2003. Development and validation of a high-performance liquid chromatography assay for voriconazole. Antimicrob. Agents Chemother. 47:2348-2350.  [DOI](https://doi.org/10.1128/AAC.47.7.2348-2350.2003) | [PMC free article](/articles/PMC161850/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/12821496/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Antimicrob.%20Agents%20Chemother.&volume=47&publication_year=2003&pages=2348&pmid=12821496&doi=10.1128/AAC.47.7.2348-2350.2003&)

6. Purkins, L., N. Wood, P. Ghahramani, K. Greenhalgh, M. J. Allen, and D. Kleinermans. 2002. Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens. Antimicrob. Agents Chemother. 46:2546-2553.  [DOI](https://doi.org/10.1128/AAC.46.8.2546-2553.2002) | [PMC free article](/articles/PMC127341/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/12121931/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Antimicrob.%20Agents%20Chemother.&volume=46&publication_year=2002&pages=2546&pmid=12121931&doi=10.1128/AAC.46.8.2546-2553.2002&)

7. Rengelshausen, J., M. Banfield, K. D. Riedel, J. Burhenne, J. Weiss, T. Thomsen, I. Walter-Sack, W. E. Haefeli, and G. Mikus. 2005. Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics. Clin. Pharmacol. Ther. 78:25-33.  [DOI](https://doi.org/10.1016/j.clpt.2005.01.024) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/16003289/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clin.%20Pharmacol.%20Ther.&volume=78&publication_year=2005&pages=25&pmid=16003289&doi=10.1016/j.clpt.2005.01.024&)

8. Shah, V. P., K. K. Midha, J. W. Findlay, H. M. Hill, J. D. Hulse, I. J. McGilveray, G. McKay, K. J. Miller, R. N. Patnaik, M. L. Powell, A. Tonelli, C. T. Viswanathan, and A. Yacobi. 2000. Bioanalytical method validation—a revisit with a decade of progress. Pharm. Res. 17:1551-1557.  [DOI](https://doi.org/10.1023/a:1007669411738) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/11303967/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Pharm.%20Res.&volume=17&publication_year=2000&pages=1551&pmid=11303967&doi=10.1023/a:1007669411738&)

9. Shimizu, T., H. Ochiai, F. Asell, H. Shimizu, R. Saitoh, Y. Hama, J. Katada, M. Hashimoto, H. Matsui, K. Taki, T. Kaminuma, M. Yamamoto, Y. Aida, A. Ohashi, and N. Ozawa. 2003. Bioinformatics research on inter-racial difference in drug metabolism. I. Analysis on frequencies of mutant alleles and poor metabolizers on CYP2D6 and CYP2C19. Drug Metab. Pharma-cokinet. 18:48-70.  [DOI](https://doi.org/10.2133/dmpk.18.48) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/15618719/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Drug%20Metab.%20Pharma-cokinet.&volume=18&publication_year=2003&pages=48&pmid=15618719&doi=10.2133/dmpk.18.48&)

10. Wilkinson, G. R. 2005. Drug metabolism and variability among patients in drug response. N. Engl. J. Med. 352:2211-2221.  [DOI](https://doi.org/10.1056/NEJMra032424) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/15917386/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&volume=352&publication_year=2005&pages=2211&pmid=15917386&doi=10.1056/NEJMra032424&)
